News Posts List
Give the President a grade - click here
03/29/2009
MSNBC asks: If you were grading Barack Obama on his performance as president, what would he get?
Widow to kidney cancer begs President not to hurt charities
03/27/2009
My husband voted for you in the election. It was the last vote for a president he would make and he knew it.
Cancer survival rates
03/27/2009
The Daily Mail reported that "cancer survival rates in Britain (are] among the worst in Europe.
The London Marathon's charitable side
03/25/2009
Carol London, from Kings Cross, is running in this yearÂ’s marathon in memory of her 12-year-old daughter Saffron, who died in 2007 after developing a rare kidney cancer.
How to fix Medicare
03/24/2009
In How to Fix Medicare: Let's Pay Patients, Not Physicians, health economist Roger Feldman argues that a radical shift in Medicare policy is not only possible but imperative. Under Feldman's "medical indemnity" proposal, Medicare would pay each patient a fixed amount of money, reserving larger subsidies for sicker people. Patients, in turn, would select their own medical services from providers who would set their own competitive rates.
Cancer drug 'fuels tumour growth'
03/24/2009
A type of drug designed to stunt tumour growth has actually been found to fuel cancer if given at too low a dose.
ZIO-101 or darinaparsin to be tested in renal cancer
03/24/2009
In vitro testing of darinaparsin using the National Cancer Institute's human cancer cell panel detected activity against a series of tumor cell lines including lung, colon, brain, melanoma, ovarian, and kidney cancer.
The last line of defense
03/24/2009
Drugmakers have to wait for patients to trickle through other medications and many patients will be sopped up by the other drugs. It's better used as a way to get your foot in the door, as Novartis (NYSE: NVS) is trying to do with Afinitor, its kidney cancer treatment for patients who have failed current treatments.
AVEO Pharmaceuticals AV-951 Kidney Cancer Drug
03/24/2009
The company's lead product, AV-951, a potential best-in-class triple VEGF receptor inhibitor, is in a Phase 2 clinical trial in more than 270 patients with metastatic renal cell cancer and is expected to enter Phase 3 development in 2009.
Even a little alcohol ups cancer risk in women
03/23/2009
Alcohol intake was associated with decreased risks of certain cancers, including thyroid cancer, non-Hodgkin lymphoma, and renal cell carcinoma (the main type of kidney cancer).
News Feed